---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-099746"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T04:52:44.200437+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cognition Therapeutics receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Deficiency letter received on September 12, 2024; stock continues trading under CGTX.
- Company has until March 11, 2025 to regain compliance under Nasdaq Rule 5450(a)(1).
- If noncompliant, company may get second 180-day cure period upon transfer to Nasdaq Capital Market.
- No assurance of regaining compliance; delisting could occur if not cured.

## SEC filing metadata
- accession: 0001104659-24-099746
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465924099746/0001104659-24-099746-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465924099746/tm2424030d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-099746
- JSON: https://secwatch.observer/filing/0001104659-24-099746.json
- Plain text: https://secwatch.observer/filing/0001104659-24-099746.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.